Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 CAD | -3.03% | 0.00% | -8.57% |
Apr. 24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
Apr. 05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
Sales 2024 * | 1.65M 1.21M | Sales 2025 * | 2.28M 1.67M | Capitalization | 38.29M 27.99M |
---|---|---|---|---|---|
Net income 2024 * | -4M -2.92M | Net income 2025 * | -5M -3.66M | EV / Sales 2024 * | 23.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 16.8 x |
P/E ratio 2024 * |
-8
x | P/E ratio 2025 * |
-8
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.72% |
1 day | -3.03% | ||
Current month | -3.03% | ||
1 month | -11.11% | ||
6 months | -13.51% | ||
Current year | -8.57% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 89-08-21 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 19-06-26 |
Arkady Mandel
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 89-08-21 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 19-06-26 |
Randy Bruder
BRD | Director/Board Member | - | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.16 | -3.03% | 65,575 |
24-04-25 | 0.165 | 0.00% | 82,500 |
24-04-24 | 0.165 | 0.00% | 1,500 |
24-04-23 | 0.165 | 0.00% | 63,500 |
24-04-22 | 0.165 | +3.13% | 87,280 |
Delayed Quote Toronto S.E., April 26, 2024 at 12:47 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.57% | 27.97M | |
-37.75% | 12.3M | |
+19.38% | 994M | |
-32.70% | 212M | |
-35.85% | 74.33M |
- Stock Market
- Equities
- TLT Stock